Suppr超能文献

利用邻近延伸分析鉴定出新型严重创伤性脑损伤血液预后生物标志物。

Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay.

机构信息

Lawson Health Research Institute, London, ON, Canada.

Pediatrics, Western University, London, ON, Canada.

出版信息

Clin Chem Lab Med. 2021 Jun 21;59(10):1662-1669. doi: 10.1515/cclm-2021-0103. Print 2021 Sep 27.

Abstract

OBJECTIVES

Severe traumatic brain injury (sTBI) patients suffer high mortality. Accurate prognostic biomarkers have not been identified. In this exploratory study, we performed targeted proteomics on plasma obtained from sTBI patients to identify potential outcome biomarkers.

METHODS

Blood sample was collected from patients admitted to the ICU suffering a sTBI, using standardized clinical and computerized tomography (CT) imaging criteria. Age- and sex-matched healthy control subjects and sTBI patients were enrolled. Targeted proteomics was performed on plasma with proximity extension assays (1,161 proteins).

RESULTS

Cohorts were well-balanced for age and sex. The majority of sTBI patients were injured in motor vehicle collisions and the most frequent head CT finding was subarachnoid hemorrhage. Mortality rate for sTBI patients was 40%. Feature selection identified the top performing 15 proteins for identifying sTBI patients from healthy control subjects with a classification accuracy of 100%. The sTBI proteome was dominated by markers of vascular pathology, immunity/inflammation, cell survival and macrophage/microglia activation. Receiver operating characteristic (ROC) curve analyses demonstrated areas-under-the-curves (AUC) for identifying sTBI that ranged from 0.870-1.000 (p≤0.005). When mortality was used as outcome, ROC curve analyses identified the top 3 proteins as Willebrand factor (vWF), Wnt inhibitory factor-1 (WIF-1), and colony stimulating factor-1 (CSF-1). Combining vWF with either WIF-1 or CSF-1 resulted in excellent mortality prediction with AUC of 1.000 for both combinations (p=0.011).

CONCLUSIONS

Targeted proteomics with feature classification and selection distinguished sTBI patients from matched healthy control subjects. Two protein combinations were identified that accurately predicted sTBI patient mortality. Our exploratory findings require confirmation in larger sTBI patient populations.

摘要

目的

严重创伤性脑损伤(sTBI)患者死亡率高。尚未确定准确的预后生物标志物。在这项探索性研究中,我们对 sTBI 患者的血浆进行了靶向蛋白质组学分析,以鉴定潜在的预后生物标志物。

方法

使用标准化的临床和计算机断层扫描(CT)成像标准,从 ICU 收治的 sTBI 患者中采集血样。招募了年龄和性别匹配的健康对照和 sTBI 患者。使用邻近延伸测定法(1,161 种蛋白质)对血浆进行靶向蛋白质组学分析。

结果

队列在年龄和性别方面平衡良好。大多数 sTBI 患者是在机动车事故中受伤的,最常见的头部 CT 发现是蛛网膜下腔出血。sTBI 患者的死亡率为 40%。特征选择确定了前 15 个最佳蛋白质,用于从健康对照组中识别 sTBI 患者,分类准确率为 100%。sTBI 蛋白质组主要由血管病理学、免疫/炎症、细胞存活和巨噬细胞/小胶质细胞激活的标志物组成。受试者工作特征(ROC)曲线分析表明,用于识别 sTBI 的曲线下面积(AUC)范围为 0.870-1.000(p≤0.005)。当死亡率用作结局时,ROC 曲线分析确定了前 3 个蛋白质为血管性血友病因子(vWF)、Wnt 抑制因子-1(WIF-1)和集落刺激因子-1(CSF-1)。vWF 与 WIF-1 或 CSF-1 联合使用可实现出色的死亡率预测,两种组合的 AUC 均为 1.000(p=0.011)。

结论

具有特征分类和选择的靶向蛋白质组学可将 sTBI 患者与匹配的健康对照组区分开来。确定了两种蛋白质组合,可准确预测 sTBI 患者的死亡率。我们的探索性发现需要在更大的 sTBI 患者群体中得到证实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验